IO Biotech (IOBT) PT Lowered to $4 at Morgan Stanley

August 11, 2025 4:26 PM EDT Send to a Friend
Morgan Stanley analyst Michael E Ulz lowered the price target on IO Biotech (NASDAQ: IOBT) to $4.00 (from $6.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login